Latest Asx Company Filings News

PainChek has achieved FDA regulatory clearance enabling its device to qualify for US Remote Therapeutic Monitoring reimbursement, positioning the company for significant growth in the expanding US healthcare market. The company also reports strong global licence growth and a solid pipeline across multiple regions.

PainChek has secured FDA De Novo clearance, enabling entry into the vast US healthcare market with a $3 billion Remote Therapeutic Monitoring opportunity. The company reports $5.6 million contracted ARR and a strong global footprint in aged care.

PentaNet Ltd reported a positive net operating cash flow of A$710,000 for the December 2025 quarter, alongside a strong cash position of A$2.42 million. The company completed its final payment for a 15-year 5G spectrum license while maintaining access to substantial financing facilities.

Pentanet has reported steady growth in Q2FY26, driven by a strong 5G revenue jump and sustained positive earnings before interest, tax, depreciation, and amortisation (EBITDA). The company’s new brand campaign and subscriber gains signal a strategic push into the second half of the fiscal year.

EVE Health Group has completed manufacturing and distribution setup for Libbo™, its innovative oral dissolving film for erectile dysfunction, paving the way for near-term patient access via telehealth and pharmacy channels.

Santa Fe Minerals has secured an 80% stake in four promising gold projects in Côte d’Ivoire, setting the stage for an active drilling campaign starting February 2026. The acquisition significantly broadens the company’s exploration footprint with high-grade targets already identified.

FlexiRoam has reported its second consecutive quarter of positive operating cash flow and returned to a positive net current asset position for the first time in over eight years, underpinned by record underlying EBITDA and strategic AI partnerships.

Alice Queen Limited is updating its Horn Island Gold Project valuation following a dramatic gold price increase, with a refreshed scoping study and resource estimate expected by mid-2026. The company has also raised $1 million to support exploration and development activities.

Janus Electric reports operational progress with validated technology and increased revenue, while focusing on commercial execution and cost discipline under new CEO Ben Hutt. Funding remains a critical factor for sustaining growth.

Sparc Technologies has marked a significant milestone with sustained hydrogen production at its pioneering pilot plant and secured key patents, while also achieving its first commercial sale of graphene additives.

Neurotech International has secured a Rare Pediatric Disease Designation from the FDA for its lead drug NTI164 targeting Rett syndrome, alongside publishing promising clinical data and raising $8.7 million to fuel further development.

One Click Group Limited has reported a robust 28% increase in revenue for 2025 alongside a significant expansion in its user base and the rollout of an upgraded cash advance product. The fintech’s strategic focus on growth and innovation sets the stage for a promising 2026.